Siga Technologies (SIGA) Competitors

$4.68 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$4.67 -0.01 (-0.21%)

As of 05/22/2026 07:21 PM Eastern

SIGA vs. WVE, ABCL, AVBP, SEPN, and CALT

Should you buy Siga Technologies stock or one of its competitors? MarketBeat compares Siga Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Siga Technologies include WAVE Life Sciences (WVE), AbCellera Biologics (ABCL), ArriVent BioPharma (AVBP), Septerna (SEPN), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry.

How does Siga Technologies compare to WAVE Life Sciences?

WAVE Life Sciences (NASDAQ:WVE) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, WAVE Life Sciences had 10 more articles in the media than Siga Technologies. MarketBeat recorded 11 mentions for WAVE Life Sciences and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.45 beat WAVE Life Sciences' score of 0.07 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WAVE Life Sciences	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Siga Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Siga Technologies has a net margin of 21.58% compared to WAVE Life Sciences' net margin of -255.70%. Siga Technologies' return on equity of 10.60% beat WAVE Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WAVE Life Sciences	-255.70%	-56.76%	-42.80%
Siga Technologies	21.58%	10.60%	8.94%

89.7% of WAVE Life Sciences shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 24.3% of WAVE Life Sciences shares are held by insiders. Comparatively, 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Siga Technologies has higher revenue and earnings than WAVE Life Sciences. WAVE Life Sciences is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WAVE Life Sciences	$42.73M	28.73	-$204.38M	-$1.06	N/A
Siga Technologies	$94.57M	3.55	$23.28M	$0.27	17.33

WAVE Life Sciences has a beta of -1.32, meaning that its stock price is 232% less volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

WAVE Life Sciences presently has a consensus price target of $27.25, suggesting a potential upside of 327.12%. Given WAVE Life Sciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe WAVE Life Sciences is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WAVE Life Sciences	1 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.87
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Siga Technologies beats WAVE Life Sciences on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to AbCellera Biologics?

Siga Technologies (NASDAQ:SIGA) and AbCellera Biologics (NASDAQ:ABCL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

AbCellera Biologics has a consensus price target of $7.80, suggesting a potential upside of 50.00%. Given AbCellera Biologics' stronger consensus rating and higher possible upside, analysts plainly believe AbCellera Biologics is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
AbCellera Biologics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Siga Technologies has higher revenue and earnings than AbCellera Biologics. AbCellera Biologics is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$94.57M	3.55	$23.28M	$0.27	17.33
AbCellera Biologics	$75.13M	21.14	-$146.41M	-$0.48	N/A

In the previous week, Siga Technologies and Siga Technologies both had 1 articles in the media. AbCellera Biologics' average media sentiment score of 0.95 beat Siga Technologies' score of 0.45 indicating that AbCellera Biologics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Siga Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AbCellera Biologics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 61.4% of AbCellera Biologics shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 28.4% of AbCellera Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Siga Technologies has a net margin of 21.58% compared to AbCellera Biologics' net margin of -181.75%. Siga Technologies' return on equity of 10.60% beat AbCellera Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	21.58%	10.60%	8.94%
AbCellera Biologics	-181.75%	-14.86%	-10.62%

Siga Technologies has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, AbCellera Biologics has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market.

Summary

AbCellera Biologics beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to ArriVent BioPharma?

ArriVent BioPharma (NASDAQ:AVBP) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Siga Technologies has a net margin of 21.58% compared to ArriVent BioPharma's net margin of 0.00%. Siga Technologies' return on equity of 10.60% beat ArriVent BioPharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ArriVent BioPharma	N/A	-48.98%	-45.44%
Siga Technologies	21.58%	10.60%	8.94%

9.5% of ArriVent BioPharma shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 8.6% of ArriVent BioPharma shares are owned by insiders. Comparatively, 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

ArriVent BioPharma has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

In the previous week, Siga Technologies had 1 more articles in the media than ArriVent BioPharma. MarketBeat recorded 1 mentions for Siga Technologies and 0 mentions for ArriVent BioPharma. Siga Technologies' average media sentiment score of 0.45 beat ArriVent BioPharma's score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
ArriVent BioPharma	Neutral
Siga Technologies	Neutral

ArriVent BioPharma presently has a consensus price target of $43.13, indicating a potential upside of 61.34%. Given ArriVent BioPharma's stronger consensus rating and higher possible upside, research analysts plainly believe ArriVent BioPharma is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ArriVent BioPharma	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.91
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Siga Technologies has higher revenue and earnings than ArriVent BioPharma. ArriVent BioPharma is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ArriVent BioPharma	N/A	N/A	-$166.31M	-$3.47	N/A
Siga Technologies	$94.57M	3.55	$23.28M	$0.27	17.33

Summary

Siga Technologies beats ArriVent BioPharma on 10 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Septerna?

Septerna (NASDAQ:SEPN) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Siga Technologies has higher revenue and earnings than Septerna. Septerna is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Septerna	$45.95M	27.82	-$48.88M	-$0.81	N/A
Siga Technologies	$94.57M	3.55	$23.28M	$0.27	17.33

Septerna currently has a consensus target price of $43.13, indicating a potential upside of 52.06%. Given Septerna's stronger consensus rating and higher probable upside, research analysts clearly believe Septerna is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Septerna	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Siga Technologies had 1 more articles in the media than Septerna. MarketBeat recorded 1 mentions for Siga Technologies and 0 mentions for Septerna. Siga Technologies' average media sentiment score of 0.45 beat Septerna's score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Septerna	Neutral
Siga Technologies	Neutral

55.4% of Siga Technologies shares are owned by institutional investors. 4.3% of Septerna shares are owned by company insiders. Comparatively, 2.7% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Siga Technologies has a net margin of 21.58% compared to Septerna's net margin of -49.88%. Siga Technologies' return on equity of 10.60% beat Septerna's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Septerna	-49.88%	-12.72%	-8.87%
Siga Technologies	21.58%	10.60%	8.94%

Septerna has a beta of 2.21, indicating that its share price is 121% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Summary

Siga Technologies beats Septerna on 10 of the 17 factors compared between the two stocks.

How does Siga Technologies compare to Calliditas Therapeutics AB (publ)?

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Siga Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

Siga Technologies has a net margin of 21.58% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. Siga Technologies' return on equity of 10.60% beat Calliditas Therapeutics AB (publ)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Calliditas Therapeutics AB (publ)	-30.18%	-212.04%	-27.96%
Siga Technologies	21.58%	10.60%	8.94%

2.8% of Calliditas Therapeutics AB (publ) shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are held by insiders. Comparatively, 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Siga Technologies has lower revenue, but higher earnings than Calliditas Therapeutics AB (publ). Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Calliditas Therapeutics AB (publ)	$1.60B	0.74	-$43.96M	-$1.85	N/A
Siga Technologies	$94.57M	3.55	$23.28M	$0.27	17.33

In the previous week, Siga Technologies had 1 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 1 mentions for Siga Technologies and 0 mentions for Calliditas Therapeutics AB (publ). Siga Technologies' average media sentiment score of 0.45 beat Calliditas Therapeutics AB (publ)'s score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Calliditas Therapeutics AB (publ)	Neutral
Siga Technologies	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Calliditas Therapeutics AB (publ)	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Siga Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Calliditas Therapeutics AB (publ) has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

Summary

Siga Technologies beats Calliditas Therapeutics AB (publ) on 12 of the 14 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SIGA vs. The Competition

Export

Metric	Siga Technologies	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$335.67M	$3.04B	$6.46B	$12.34B
Dividend Yield	N/A	1.97%	2.76%	5.28%
P/E Ratio	17.33	17.79	21.21	25.65
Price / Sales	3.55	336.21	554.38	86.31
Price / Cash	14.06	57.74	43.49	56.67
Price / Book	2.22	5.86	10.37	7.14
Net Income	$23.28M	$74.99M	$3.57B	$335.98M
7 Day Performance	7.09%	3.11%	6.40%	4.15%
1 Month Performance	2.41%	-3.05%	3.53%	2.54%
1 Year Performance	-20.81%	34.38%	34.04%	35.06%

Siga Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
SIGA Siga Technologies	1.0822 of 5 stars	$4.68 flat	N/A	-20.8%	$335.67M	$94.57M	17.33	40
WVE WAVE Life Sciences	3.1437 of 5 stars	$6.43 +0.5%	$27.19 +322.7%	+7.2%	$1.24B	$42.73M	N/A	240
ABCL AbCellera Biologics	3.0619 of 5 stars	$4.04 -3.0%	$7.80 +93.3%	+164.0%	$1.23B	$75.13M	N/A	500
AVBP ArriVent BioPharma	2.3725 of 5 stars	$26.45 -2.2%	$42.78 +61.7%	+31.0%	$1.23B	N/A	N/A	40
SEPN Septerna	2.8584 of 5 stars	$27.05 +2.9%	$43.13 +59.4%	+208.6%	$1.21B	$45.95M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Siga Technologies (SIGA) Competitors

SIGA vs. WVE, ABCL, AVBP, SEPN, and CALT

How does Siga Technologies compare to WAVE Life Sciences?

Summary

How does Siga Technologies compare to AbCellera Biologics?

Summary

How does Siga Technologies compare to ArriVent BioPharma?

Summary

How does Siga Technologies compare to Septerna?

Summary

How does Siga Technologies compare to Calliditas Therapeutics AB (publ)?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Siga Technologies (SIGA) Competitors

SIGA vs. WVE, ABCL, AVBP, SEPN, and CALT

How does Siga Technologies compare to WAVE Life Sciences?

Does the media prefer WVE or SIGA?

Is WVE or SIGA more profitable?

Do insiders & institutionals hold more shares of WVE or SIGA?

Which has stronger earnings & valuation, WVE or SIGA?

Which has more risk & volatility, WVE or SIGA?

Do analysts prefer WVE or SIGA?

Summary

How does Siga Technologies compare to AbCellera Biologics?

Do analysts prefer SIGA or ABCL?

Which has stronger valuation and earnings, SIGA or ABCL?

Does the media refer more to SIGA or ABCL?

Do insiders and institutionals believe in SIGA or ABCL?

Is SIGA or ABCL more profitable?

Which has more volatility and risk, SIGA or ABCL?

Summary

How does Siga Technologies compare to ArriVent BioPharma?

Is AVBP or SIGA more profitable?

Do institutionals and insiders believe in AVBP or SIGA?

Which has more volatility and risk, AVBP or SIGA?

Does the media prefer AVBP or SIGA?

Do analysts recommend AVBP or SIGA?

Which has preferable valuation and earnings, AVBP or SIGA?

Summary

How does Siga Technologies compare to Septerna?

Which has better earnings & valuation, SEPN or SIGA?

Do analysts prefer SEPN or SIGA?

Does the media prefer SEPN or SIGA?

Do insiders & institutionals have more ownership in SEPN or SIGA?

Is SEPN or SIGA more profitable?

Which has more volatility & risk, SEPN or SIGA?

Summary

How does Siga Technologies compare to Calliditas Therapeutics AB (publ)?

Is CALT or SIGA more profitable?

Do insiders & institutionals hold more shares of CALT or SIGA?

Which has preferable earnings and valuation, CALT or SIGA?

Does the media prefer CALT or SIGA?

Do analysts recommend CALT or SIGA?

Which has more risk and volatility, CALT or SIGA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools